N,N-substituted 3-aminopyrrolidine compounds useful as...

Details N,N-substituted 3-aminopyrrolidine compounds useful as... N,N-substituted 3-aminopyrrolidine compounds useful as...

2006-05-12

2011-12-27

Loewe, Sun Jae (Department: 1622)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Silicon containing doai

C514S230500, C514S252050, C514S255050, C514S423000, C544S105000, C544S238000, C544S336000, C548S531000

Reexamination Certificate

active

08084442

ABSTRACT:
The present invention provides a pyrrolidine compound of General Formula (1)or a salt thereof, wherein R101and R102are each independently a phenyl group or a pyridyl group, the phenyl group or the pyridyl group may have one or more substituents selected from halogen atoms and lower alkyl groups optionally substituted with one or more halogen atoms, etc. The pyrrolidine compound or a salt thereof of the present invention is usable to produce a pharmaceutical preparation having a wider therapeutic spectrum and being capable of exhibiting sufficient therapeutic effects after short-term administration.

REFERENCES:
patent: 3433802 (1969-03-01), Dawson et al.
patent: 3509171 (1970-04-01), Welstead, Jr. et al.
patent: 3577440 (1971-05-01), Lunsford et al.
patent: 4254135 (1981-03-01), Walsh et al.
patent: 1164828 (1969-09-01), None
patent: 1 173 373 (1969-12-01), None
patent: 1523631 (1976-09-01), None
patent: 2 295 387 (1996-05-01), None
patent: 98/28270 (1998-07-01), None
patent: 01/83434 (2001-11-01), None
patent: 02/94794 (2002-11-01), None
patent: 2004/110995 (2004-12-01), None
patent: 2004/111003 (2004-12-01), None
patent: 2005/000305 (2005-01-01), None
patent: 2005/000811 (2005-01-01), None
patent: 2005/047251 (2005-05-01), None
Pelcman et al., caplus an 1998:479507.
Alzheimer's Disease Treatment Phases, http://www.alzheimerstreatment.org/treatment/disease-treatment.htm (2008).
Alzheimer's Drugs, Consumer Reports Best Buy Drugs (p. 1-5) (2006).
Kurimura et al., caplus an 2008:733525.
Office Action dated Oct. 19, 2009 as issued in European Patent Application No. 06756356.9.
Sadanori Miura, “Rinshoseishinyakuri”, Japanese Journal of Clinical Psychopharmacology, 2000, vol. 3, pp. 311-318.
Phil Skolnick, “Antidepressants for the new millennium”, European Jounal of Pharmacology 375, 1999, pp. 31-40.
Office Action dated Oct. 16, 2009 as issued in European Patent Application No. 06756356.9.
Examination Report for Australian Patent Application No. 2010201952, dated Jun. 2, 2011.

Affiliated with

Also associated with

Rating

N,N-substituted 3-aminopyrrolidine compounds useful as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N,N-substituted 3-aminopyrrolidine compounds useful as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N,N-substituted 3-aminopyrrolidine compounds useful as... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4298566